期刊文献+

美国临床生化科学院和国际临床化学联合会心脏损伤标志物标准化委员会检验医学实践指南:心力衰竭生物标志物检测问题 被引量:1

下载PDF
导出
出处 《临床检验杂志》 CAS CSCD 北大核心 2009年第5期I0035-I0037,共3页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献30

  • 1Apple F S, Panteghini M, Ravkilde J, et al. Qualityspecifications for B-type natriuretic peptide assays [ J ]. Clin Chem, 2005,51 : 486- 493.
  • 2Bossuyt P M, Reitsma J B, Bruns D B, et al. The STARD statement for reporting of diagnostic accuracy: explanation and elaboration[ J]. Clin Chem, 2003, 49: 7-18.
  • 3Maisel A S, Krishnaswamy P, Nowak R M, et al. for the BNP Multinational Study Investigators. Rapid measurement of B-type natriuetic peptide in the emergency diagnosis of heart failure [ J ]. N Engl J Med, 2002, 347 : 161-167.
  • 4Brandt I, Lambeir A M, Ketelslegers J M, et al. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form[ J]. Clin Chem, 2006,52:82-87.
  • 5Shimizu H, Masuta K, Asada H, et al. Characterization of molecular forms of probrain natriuretic peptide in human plasma[ J ]. Clin Chim Acta, 2003,334:233-239.
  • 6Panteghini M, Clerico A. Cardiac natriuretic hormones as markers of cardiovascular disease: methodological aspects [ J ]. In : Clerieo A, Emdin M, eds. Natriuretie peptides. The hormones of the heart. Springer: Berlin, 2006, 65-89.
  • 7Giuliani I, Rieunier F, Larue C, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood [ J ]. Clin Chem, 2006,52: 1054-1061.
  • 8Liang F, O' Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coil Cardiol, 2007; In press; first access as doi: 10. 1016/j/jacc. 2006.10. 063.
  • 9Schellenberger U, ORear J, Guzzetta A, et al. The precursor to B-type natriuretic peptide is an O-linked glycoprotein [ J ]. Arch Biochem Biophys, 2006,451 : 160-166.
  • 10Seferian K R ,Tamm N T, Semenov A G, et al. The BNp precursor is the major immunoreactive form of BNP in patients with heart failure[J]. Clin Chem, 2007,53:866-873.

同被引文献11

  • 1CLSI EP15-A2. User demonstration of performance for precision andaccuracy; Approved guideline-second Edition ( EP15-A2 ) [ S ]. Wayne : CLS1,2004.
  • 2CLSI EP17-A. Protocols for Determination of Limits of Detection and Limits of Quantitation ; Approved Guideline ( EP17-A ) [ S ]. Wayne : CLSI, 2004.
  • 3CLSI EP6-A. User demonstration of performance for precision and ac- curacy ; Approved Guideline (EP6-A) [ S ]. Wayne : CLS1,2004.
  • 4CLSI EP7-A2. Interference testing in clinical chemistry; Approved Guideline-second Edition ( EP7-A2 ) [ S ]. Wayne : CLSI,2005.
  • 5Wu AH, Packer M, Smith A, et al. Analytical and clinical evalua- tion of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study [ J ]. Clin Chem,2004,50(5):867-873.
  • 6Rawlins ML, Owen WE, Roberts WL. Performance characteristics of four automated natriuretic peptide assays [ J]. Am J Clin Pathol, 2005,123 (3) :439-445.
  • 7Wians FH Jr, Wilson BA, Grant A, et al. Evaluation of the analyti- cal performance characteristics of the Bayer ACS: 180 R B-type na- triuretic peptide (BNP) assay[ J]. Clin Chim Acta, 2005, 353 ( 1- 2) : 147-155.
  • 8Prontera C, Zaninotto M, Giovannini S, et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the Car- dioOrmocheck study [ J ]. Clin Chem Lab Med, 2009, 47 (6) : 762-768.
  • 9王学晶,徐国宾,李海霞,焦莉莉.化学发光免疫分析法测定血浆B型钠尿肽的评价及其参考区间调查[J].临床检验杂志,2009,27(4):283-285. 被引量:5
  • 10急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:835

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部